Evaluation of efficacy, safety, and tolerability of fixed dose combination (FDC) of halometasone 0.05% and fusidic acid 2% w/w topical cream versus FDC of betamethasone valerate 0.12% and neomycin sulphate 0.5% w/w topical cream in the treatment of infected eczematous dermatosis in Indian subjects: A randomized open-label comparative phase III multi-centric trial

• Asıl Yazarlar: Dasiga Venkata Subrahmanya Pratap (Yazar), Mariam Philip (Yazar), Narayana T Rao (Yazar), Hemangi R Jerajani (Yazar), Sainath A Kumar (Yazar), Maria Kuruvila (Yazar), Latha S Moodahadu (Yazar), Shilpi Dhawan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wolters Kluwer Medknow Publications, 2013-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Aim: To evaluate the efficacy and safety of fixed drug combination (FDC) halometasone 0.05% and fusidic acid 2% (group A) vs FDC betamethasone 0.12% and neomycin sulfate 0.5% cream (group B) in acute or chronic infected eczematous dermatosis, through a randomized open-label, comparative, multicentri...